Latkauskas, T. et al. BMC Cancer. Published: 1 December 2016
Background: There still is no evidence which neoadjuvant therapy regimen for stage II–III rectal cancer is superior. The aim of this study was to compare results achieved after long-course chemoradiotherapy (CRT) with short-term radiotherapy (RT) followed by delayed surgery.
Conclusion: Three-years disease-free survival was better in CRT group comparing with RT group with no difference in overall survival.
Read the full article here